Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...

Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...

India’s 21st century growth story is turning biological. From vaccines to genome sequencing and green fuels, biotechnology is ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...

Can gene editing truly support smallholder farmers and help Indonesia achieve food sovereignty, or will it simply revive the ...

Atlantic County Institute of Technology (ACIT) is in the final group of county vocational-technical schools to complete its ...

Using a technique called ancestral sequence reconstruction (ASR), researchers at Wageningen University & Research in the ...

An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for ...